Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec 24:8:6.
doi: 10.1186/1476-5918-8-6.

The effects of age on skeletal muscle and the phosphocreatine energy system: can creatine supplementation help older adults

Affiliations

The effects of age on skeletal muscle and the phosphocreatine energy system: can creatine supplementation help older adults

Vincent J Dalbo et al. Dyn Med. .

Abstract

Creatine supplementation has been found to significantly increase muscle strength and hypertrophy in young adults (</= 35 yr) particularly when consumed in conjunction with a resistance training regime. Literature examining the efficacy of creatine supplementation in older adults (55-82 yr) suggests creatine to promote muscle strength and hypertrophy to a greater extent than resistance training alone. The following is a review of literature reporting on the effects of creatine supplementation on intramuscular high energy phosphates, skeletal muscle morphology and quality of life in older adults. Results suggest creatine supplementation to be a safe, inexpensive and effective nutritional intervention, particularly when consumed in conjunction with a resistance training regime, for slowing the rate of muscle wasting that is associated with aging. Physicians should strongly consider advising older adults to supplement with creatine and to begin a resistance training regime in an effort to enhance skeletal muscle strength and hypertrophy, resulting in enhanced quality of life.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Giresi PG, Stevenson EJ, Theilhaber J, Koncarevic A, Parkington J, Fielding RA, Kandarian SC. Identification of a molecular signature of sarcopenia. Physiol Genomics. 2005;21:253–263. doi: 10.1152/physiolgenomics.00249.2004. - DOI - PubMed
    1. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52:80–85. doi: 10.1111/j.1532-5415.2004.52014.x. - DOI - PubMed
    1. Borst SE. Interventions for sarcopenia and muscle weakness in older people. Age Ageing. 2004;33:548–555. doi: 10.1093/ageing/afh201. - DOI - PubMed
    1. Kamel HK. Sarcopenia and aging. Nutr Rev. 2003;61:157–167. doi: 10.1301/nr.2003.may.157-167. - DOI - PubMed
    1. Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, Bhasin S. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci. 2005;60:1451–1457. - PubMed

LinkOut - more resources